Kiromic BioPharma, Inc. announced that the Board of Directors approved a restructuring of the committees, effective as of November 12, 2020. In connection with the Committee Restructuring, the Board appointed members to each such committee. Audit Committee includes- Pietro Bersani (Chairperson), Jerry Schneider and Michael Nagel. Compensation Committee includes- Jerry Schneider (Chairperson), Americo Cicchetti and Pietro Bersani. Nominating Committee includes- Michael Nagel (Chairperson), Americo Cicchetti and Pietro Bersani.